Pharmaceutical Preparations · NV · CIK 1430306
Tonix Pharmaceuticals develops and commercializes innovative therapies for CNS disorders, immunology, infectious diseases, and rare diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 18, 2026: 1 insider bought $223K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Lederman SethChief Executive Officer | Buy | 15,000 | $14.89 | $223K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.